CA2367628A1 - Cryosurgical fluid supply - Google Patents

Cryosurgical fluid supply Download PDF

Info

Publication number
CA2367628A1
CA2367628A1 CA002367628A CA2367628A CA2367628A1 CA 2367628 A1 CA2367628 A1 CA 2367628A1 CA 002367628 A CA002367628 A CA 002367628A CA 2367628 A CA2367628 A CA 2367628A CA 2367628 A1 CA2367628 A1 CA 2367628A1
Authority
CA
Canada
Prior art keywords
cryogenic
fluid
cooling
delivery system
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002367628A
Other languages
French (fr)
Other versions
CA2367628C (en
Inventor
James Joye
Richard S. Williams
Ronald Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CryoVascular Systems Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2367628A1 publication Critical patent/CA2367628A1/en
Application granted granted Critical
Publication of CA2367628C publication Critical patent/CA2367628C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B18/0218Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22054Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation with two balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0212Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument inserted into a body lumen, e.g. catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0231Characteristics of handpieces or probes
    • A61B2018/0262Characteristics of handpieces or probes using a circulating cryogenic fluid

Abstract

Improved systems, devices, and methods for delivering cryogenic cooling fluid to cryosurgical probes such as cryosurgical endovascular balloon catheters take advantage of the transients during the initiation and termination of cryogenic fluid flow to moderate the treatment temperatures of tissues engaged by the probe. A flow limiting element along a cryogenic fluid path intermittently interrupts the flow of cooling fluid, often cycling both the fluid flow and treatment temperature. This can maintain the tissue treatment temperature within a predetermined range which is above the treatment temperature provided by a steady flow of cryogenic fluid. In another aspect, room temperature single-use cooling fluid cartridges are filled with a sufficient quantity of cryosurgical fluid to effect a desired endovascular cryosurgical treatment.

Description

CRYOSURGICAL FLUID SUPPLY
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates generally to apparatus and methods for cryosurgical therapy. In a particular embodiment, the invention provides a cryosurgical fluid delivery system which makes use of transients in the cooling cycle to moderate the cooling effects of a cryosurgical endovascular balloon catheter.
A number of percutaneous intravascular procedures have been developed for treating atherosclerotic disease in a patient's vasculature. The most successful of these treatments is percutaneous transluminal angioplasty (PTA). PTA employs a catheter having an expansible distal end (usually in the form of an inflatable balloon) to dilate a stenotic region in the vasculature to restore adequate blood flow beyond the stenosis.
Other procedures for opening stenotic regions include directional arthrectomy, rotational arthrectomy, laser angioplasty, stenting, and the like. While these procedures have gained wide acceptance (either alone or in combination, particularly PTA in combination with stenting), they continue to suffer from significant disadvantages. A
particularly common disadvantage with PTA and other known procedures for opening stenotic regions is the subsequent occurrence of restenosis.
Restenosis refers to the re-narrowing of an artery following an initially successful angioplasty or other primary treatment. Restenosis typically occurs within weeks or months of the primary procedure, and may affect up to 50% of all angioplasty patients to some extent. Restenosis results at least in part from smooth muscle cell proliferation in response to the injury caused by the primary treatment. This cell proliferation is referred to as "hyperplasia." Blood vessels in which significant restenosis occurs will typically require further treatment.
A number of strategies have been proposed to treat hyperplasia and reduce restenosis. Previously proposed strategies include prolonged balloon inflation, treatment of the blood vessel with a heated balloon, treatment of the blood vessel with radiation, the administration of anti-thrombotic drugs following the primary treatment, stenting of the region following the primary treatment, and the like. While these proposals have enjoyed varying levels of success, no one of these procedures is proven to be entirely successful in avoiding all occurrences of restenosis and hyperplasia.
It has recently been proposed to prevent or slow reclosure of a lesion following angioplasty by remodeling the lesion using a combination of dilation and cryogenic cooling. Co-pending U.S. Patent Application Serial No. 09/203,011, filed December 1, 1998 (Attorney Docket No. 18468-000110), the full disclosure of which is incorporated herein by reference, describes an exemplary structure and method for inhibiting restenosis using a cryogenically cooled balloon. While these proposals appear promising, the described structures and methods for carrying out endovascular cryogenic cooling would benefit from still further improvements. For example, the mechanical strength of the vasculature generally requires quite a high pressure to dilate the vessel during conventional angioplasty. Conventional angioplasty often involves the inflation of an angioplasty balloon with a pressure of roughly 10 bar. These relatively high pressures can be safely used within the body when balloons are inflated with a benign liquid such as contrast or saline. However, high pressures involve some risk of significant injury should the balloon fail to contain a cryogenic gas or liquid/gas combination at these high pressures. Additionally, work in connection with the present invention has shown that the antiproliferative efficacy of endoluminal cryogenic systems can be quite sensitive to the temperature to which the tissues are cooled: although commercially available, cryogenic cooling fluids show great promise for endovascular use, it can be challenging to reproducibly effect controlled cooling without having to resort to complex, high pressure, tight tolerance, and/or expensive cryogenic control components.
For these reasons, it would be desirable to provide improved devices, systems and methods for effecting cryosurgical and/or other low temperature therapies. It would further be desirable if these improved techniques were capable of delivering cryosurgical cooling fluids into the recently proposed endovascular cryosurgical balloon catheters, as well as other known cryosurgical probes. It would be particularly desirable if these improved techniques delivered the cryosurgical cooling fluid in a safe and controlled manner so as to avoid injury to adjacent tissues, ideally without requiring a complex control system and/or relying entirely on the operator's skill to monitor and control these temperature-sensitive treatments.
2. Description of the Background Art A cryoplasty device and method are described in WO 98/38934. Balloon catheters for intravascular cooling or heating of a patient are described in U.S. Patent No. 5,486,208 and WO 91/05528. A cryosurgical probe with an inflatable bladder for performing intrauterine ablation is described in U.S. Patent No. 5,501,681.
Cryosurgical probes relying on Joule-Thomson cooling are described in U.S. Patent Nos.
5,275,595;
5,190,539; 5,147,355; 5,078,713; and 3,901,241. Catheters with heated balloons for post-angioplasty and other treatments are described in U.S. Patent Nos. 5,196,024;
5,191,883;
5,151,100; 5,106,360; 5,092,841; 5,041,089; 5,019,075; and 4,754,752.
Cryogenic fluid sources are described in U.S. Patent Nos. 5,644,502; 5,617,739; and 4,336,691.
The following U.S. Patents may also be relevant to the present invention:
5,458,612;
5,545,195; and 5,733,280.
The full disclosures of each of the above U.S. patents are incorporated by reference.
SUMMARY OF THE INVENTION
The present invention generally overcomes the advantages of the prior art by providing improved systems, devices, and methods for delivering cryogenic cooling fluid to cryosurgical probes, such as the new cryosurgical endovascular balloon catheters.
The invention generally takes advantage of the transients during the initiation and termination of cryogenic fluid flow to moderate the treatment temperatures of tissues engaged by the probe. In some embodiments, a flow limiting element along a cryogenic fluid path intermittently interrupts the flow of cooling fluid, often cycling both the fluid flow and treatment temperature. This can help maintain the tissue treatment temperature within a predetermined range which is significantly above the treatment temperature which would be provided by a steady flow of cryogenic fluid. This intermittent flow may decrease sensitivity of the system to the particular configuration of the exhaust gas of flow path defined by a flexible catheter body disposed within the vascular system.
Cooling of the vessel along the catheter body proximally of a balloon may also be decreased, thereby avoiding the embolization of frozen blood within the vasculature. In another aspect, the invention makes use of a single-use cooling fluid cartridges which may be transported safely at room temperature when filled with a sufficient quantity of cryosurgical fluid to effect a desired treatment, and which can be safely and cost-effectively disposed of after use.
In a first aspect, the invention provides a cryogenic fluid delivery system for use with a cryogenic probe having a cryogenic fluid input and a cooling surface for engaging a target tissue. The cryogenic delivery system comprises a cooling fluid container having a cryogenic fluid output. A cooling fluid path couples the fluid output of the container to the fluid input of the probe. A flow interrupter disposed along the cooling fluid path intermittently inhibits the flow of cryogenic cooling fluid from the container to the probe so as to limit cooling by the cooling surface.
A variety of flow interrupter structures may be used to moderate cooling of the target tissue. For example, the flow interrupter may comprise a solenoid valve, which will often be driven by a simple intermittent timing switch, a timing circuit, or the like.
Alternatively, the flow interrupter may comprise a valve member rotatably engaging a valve body so as to provide fluid communication when the valve member is in a first rotational position and inhibit fluid communication when the valve is in a second rotational position. Such a rotatable valve assembly will often be driven by a motor, such as an electric motor, a pneumatic motor, or the like. Still further alternative fluid interrupters may comprise a deformable cryogenic conduit which can be occluded by actuation of a solenoid, pneumatic ram, or the like.
In another aspect, the invention provides a cryogenic fluid delivery system for use with a cryogenic probe. The probe has a cryogenic fluid input and a cooling surface, and the delivery system includes a cooling fluid container having a cryogenic fluid output. A cryogenic cooling fluid is disposed in the fluid container, and a cooling fluid path couples the fluid output of the container to the fluid input of the probe. Means are disposed along the cooling fluid path for limiting cooling of the cooled surface by intermittently inhibiting cooling fluid flow from the container to the probe.
In another aspect, the invention provides a single-use cryogenic fluid delivery system for use with a cryogenic endovascular catheter so as to inhibit hyperplasia of a diseased blood vessel region of a patient body. The cryogenic delivery system comprises a cooling fluid container and a connector for coupling to the catheter.
A cooling fluid path provides fluid communication from the container to the connector.
The path has a seal, and a cryogenic cooling fluid is disposed within the fluid container.
The cooling fluid has a quantity and is at a pressure such that the catheter will cool the blood vessel to a temperature in a predetermined temperature range so as to inhibit hyperplasia when the connector is coupled to the catheter and the seal is opened.

Advantageously, the cryogenic fluid may be stored and transported at the desired pressure by the container when the container is at room temperature.
The quantity of cryogenic fluid may be sufficient to maintain the blood vessel within the treatment temperature range for a time in predetermined treatment time range, thereby allowing the cooling system to be substantially self controlling. Such a system is particularly useful for inhibiting hyperplasia or neoplasia, the quantity and pressure of the cryogenic fluid ideally being sufficient to cool a surface of the diseased blood vessel region to a temperature from about -5° C to about -25°C for a time from about 10 to about 60 seconds, most often for a time between about 20 and 30 seconds.
The container will often comprise a disposable cartridge having a frangible seal. The seal may be breached by a fitting which threadably engages a casing in which the container is received. Such disposable cartridges can safely maintain cryosurgical cooling fluids such as N20 at high pressures and in sufficient quantities to effect a variety of desired treatments. For example, the cartridge may contain about 5 to 30 grams of cooling fluid, and may contain Nz0 or other cooling fluids at a pressure between about 400 and 1000 psi.
In a method aspect of the present invention, a tissue of a patient body can be treated using a cooling surface of a cryosurgical probe. Such a method may comprise coupling a cryogenic fluid canister to the probe, the canister containing a pressurized cryogenic cooling fluid. The cooling fluid flows from the canister toward the cooling surface of the probe. The flow is intermittently interrupted to limit cooling of the tissue by the probe.
The interruption periodically inhibits the flow of cooling fluid to avoid cooling of a tissue below a predetermined temperature range. This can repeatedly cycle a tissue temperature, ideally reaching a temperature within a range from about -5° C to about -25° C for a time in a range from about 10 to about 60 seconds during the cycle, most often for a time between about 20 and 30 seconds. Typically, the cycling of the flow interruption and/or tissue temperature will have a period in a range from about .O1 second to about 5 seconds, the frequency ideally being in a range from about .3 to about 3 hertz.
While this summary describes many of the optional, preferred features of the exemplary embodiments, it should be understood that the invention is not limited to these specific embodiments. A fuller understanding of the specific embodiments and their operation can be obtained with reference to the drawings and description which follow.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 schematically illustrates a cryogenic/angioplasty balloon catheter system including a cryogenic fluid supply system according to the principles of the present invention.
Fig. 2 is an exploded cross-sectional view of a cryogenic fluid supply system for use in the cryosurgical system of Fig. 1.
Figs. 3A through C schematically illustrate alternative flow interrupters for moderating the treatment temperatures of a cryosurgical system.
Fig. 4 illustrates cryogenic cooling temperatures provided by expansion of N20.
Figs. SA through C graphically illustrate theoretical and measured treatment temperatures provided by an endovascular cryogenic balloon catheter system including the cryogenic fluid supply of the present invention.
Figs. 6A through C are partial cross-sections schematically illustrating the method of the present invention for inhibition of hyperplasia.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
The devices, systems, and methods of the present invention are related to co-pending U.S. Patent Application Serial No. 09/203,011, filed on December l, 1998 for an Apparatus and Method for Cryogenic Inhibition of Hyperplasia, and to co-pending U.S. Patent Application Serial No. , filed February 24, 1999 for a Cryogenic Angioplasty Catheter (Attorney Docket No. 18468-000400). These applications are assigned to the present assignee, and their full disclosures are incorporated herein by reference.
Referring now to Fig. 1, an exemplary system 10 is capable of treating a diseased vessel wall of a blood vessel using a combination of both angioplasty dilation and cryogenic cooling. In general, system 10 includes a catheter 12 coupled to a cryogenic fluid supply system 14 and an angioplasty pressurization system 16.
One or both of cryogenic system 14 and pressurization system 16 may optionally be operatively coupled to a controller 18 for coordination of cooling and dilation. In some embodiments, controller 18 may actively control cryogenic cooling by modulating cooling fluid supply rates, cooling exhaust gas port pressures, cycling of the cooling fluid flow, or the like, in response to balloon pressure, measured temperature, or the like. In other embodiments, the system will be substantially self modulating through the use of predetermined supply quantities, pressures, and/or flow cycling rates.
Catheter 12 generally includes a catheter body having a proximal end 22 and a distal end 24. A proximal housing 26 includes a number of ports for coupling of cryogenic supply system 14, pressurization system 16, and the like, to the proximal end of the catheter body. An angioplasty balloon 28 and a cryogenic balloon 30 are mounted near the distal end of catheter body 24. A catheter body will generally be flexible and contain a plurality of lumens to provide fluid communication between the ports of proximal housing 26 and balloons 28 and 30.
Angioplasty balloon 28 may be formed from a variety of materials conventionally used for dilating blood vessels. Angioplasty balloon 28 will typically comprise a non-distensible material such as polyethylene terephthalate (PET).
Such angioplasty balloons are formed in a variety of sizes depending on their intended use, typically having a length and range from about 15 mm to about 50 mm and an expanded diameter in a range from about 2 mm to about 10 mm. Prior to inflation, angioplasty balloon 28 will generally remain in a low profile configuration suitable for insertion into and maneuvering through the vascular system. A guidewire lumen 32 extends through angioplasty balloon 28 and cryogenic balloon 30 from a proximal guidewire port 34 to facilitate accessing the target treatment site.
High contrast markers may be provided within balloon 30 to enhance an image of the distal end of the catheter and facilitate positioning of the balloon fluoroscopically, sonographically, or under any other alternative image modality (with appropriate contrast structures). Such markers may be formed by winding a gold or platinum wire around the tubular structure defining a pressurization lumen 36.
Angioplasty balloon 28 is inflated by injecting contrast fluid 40 from pressurization system 16 into pressurization lumen 36 through a pressurization port 38. In this embodiment, balloon 28 is isolated from balloon 30, so as to avoid inadvertent inflation of the cryogenic balloon during dilation.
In the catheter illustrated in Fig. 1, cryogenic balloon 30 is nested within the angioplasty balloon 28. It should be understood that cryogenic balloon 30 may alternatively be axially displaced from the cryogenic balloon, or that a single balloon may function as both the cryogenic cooling and dilation. Cooling may be provided by containing the cryogenic cooling fluid within a rigid heat exchanger, and optionally cooling a surrounding balloon wall via a fluid having a predetermined freezing temperature. In still further alternative embodiments, cryogenic cooling catheters may be provided without dilation capabilities. Still further alternative cooling probes might benefit from the modulated cooling of the present invention, including hand-held probes connected to cooling surfaces by rigid shafts. In other words, many probe structures might benefit from the present invention. It should be understood that the supply system need not be separate or separable from the probe.
Regardless of the specific structure of the cooling surface, cryogenic fluid 60 is generally directed from an output of cryogenic fluid supply 14 to an input of the cooling probe. In the embodiment of Fig. l, the cryogenic fluid is injected into a cryogenic supply port 42 and passes toward cryogenic balloon 30 through cryogenic supply lumen 44 within catheter body 20. Cryogenic fluid 60 may comprise cryogenic liquids or liquid/gas mixtures, optionally including carbon dioxide (COZ), nitrous oxide (NZO), liquid nitrogen (N2), a fluorocarbon such as AZ -SOT"~ (sold by Genetron of Morristown, New Jersey), or the like. As cryogenic liquid 60 passes from the supply lumen and into cryogenic balloon 30, it may be distributed both radially and axially by a diffuser 46. Diffuser 46 will generally comprise a tubular structure with radially oriented openings. As the openings are radially oriented, diffuser 46 will direct the cooling fluid roughly perpendicularly toward the wall of cryogenic balloon 30, so that the heat transfer coefficient between the cooling vapor and balloon wall is quite even and quite high. This helps to reduce the temperature of the balloon wall, and provides greater heat extraction for a given flow rate of coolant. Additionally, as the ports are distributed both circumferentially and axially along the balloon, the diffuser can provide a substantially uniform cooling over a significant portion of (often over the majority of) the surface of the balloon.
In some embodiments, the cryogenic cooling fluid may pass through a Joule-Thompson orifice between fluid supply lumen 44 and balloon 30. In other embodiments, at least a portion of the cryogenic cooling fluid may exit one or more ports into the balloon as a liquid. The liquid will vaporize within the balloon, and the enthalpy of vaporization can help cool the surrounding vessel wall. The liquid may coat at least a portion of the balloon wall so as to enhance even cooling over at least a portion of the vessel wall. Hence, the ports of diffuser 46 may have a total cross-section which is smaller than a cross-section of the fluid supply lumen 44, or which is at least as large as (or larger than) the cross-section of the fluid supply lumen.
After the cryogenic cooling fluid vaporizes within balloon 30, it escapes the balloon proximally along an exhaust lumen 48, and is exhausted from catheter 12 through an exhaust port 50. Inflation of cryogenic balloon 30 may be controlled by the amount of cryogenic fluid injected into the balloon, and/or by the pressure head loss experienced by the exhaust gases. Cooling is generally enhanced by minimizing the pressure within balloon 30. To take advantage of this effect so as to control the amount of cooling, a fixed or variable orifice may be provided at exhaust port 50.
Alternatively, a vacuum might be applied to the exhaust port to control cooling and enhance cooling efficiency. In some embodiments, a layer of insulting material 72 may be disposed between the cryogenic cooling fluid and the tissue engaging surface of the balloon. A
suitable insulation material might include a thin layer of expanded TeflonT""
(ePTFE) on an inner or outer surface of cryogenic balloon 30, on an inner or outer surface of angioplasty balloon 28, or the like. A wide variety of alternative insulation materials might also be used.
To accurately control and/or monitor the pressure within cryogenic balloon 30, proximal housing 26 may include a cooling balloon pressure monitoring port 56. The pressure monitoring port will be in fluid communication with the cryogenic balloon 30, preferably through a dedicated pressure monitoring lumen (not shown).
Signals from pressure monitoring port 56 and a thermocouple connector 58 may be transmitted to the controller 18.
In use, the nested cryogenic/angioplasty balloon catheter of Fig. 1 may allow pre-cooling of a diseased vessel wall prior to dilation, cooling of a vessel wall after dilation, interspersed cooling/dilation, and even concurrent dilation during cooling. In some endovascular therapies, cooling without dilation may be desired, so that no provisions for inflation of an angioplasty balloon 28 by contrast 40 are required.
Cryogenic fluid delivery system 14 is illustrated in Fig. 2. Delivery system 14 makes use of a disposable cartridge 102 containing a cryogenic fluid 104.
Cartridge 102 is received in a casing 106, and the casing threadably engages a fitting 108.
By placing cartridge 102 in casing 106 and threading fitting 108 to the casing, a frangible seal 110 of the cartridge can be breached by a protruding tube 112 of the fitting.
Fitting 108 may include a sealing body such as a rubber washer 114 to avoid leakage of cooling fluid 104, while the fitting and casing 106 may include gripping surfaces to facilitate breaching seal 110.
Once seal 110 has been breached by fitting 108, cryogenic cooling fluid 104 passes through a lumen 116 through the fitting and on toward the balloon surface. Coupling of fluid delivery system 14 to cooling/angioplasty balloon catheter 12 is facilitated by including a detachable connector 118 along the cooling fluid flow path, the connector typically comprising a luer fitting which sealingly engages fluid supply port 42 of the catheter. While connector 118 is here shown closely coupled to fitting 108, it should be understood that the fluid flow path may follow a longer, and optionally flexible path. In fact, aspects of the present invention will find uses with standard reusable cryogenic fluid supply system.
In fluid delivery system 14 illustrated in Fig. 2, a simple stopcock 120 is disposed between fitting 108 and connector 118. Stopcock 120 allows the cryogenic system operator to pierce seal 110 of cartridge 102 while setting up the system, and to later manually initiate flow of the cooling fluid by turning a lever of the stopcock. A port on stopcock 120 may be in fluid communication with the open cooling fluid path to verify cooling fluid pressure, temperature, or the like. Alternatively, the stopcock port may be isolated from the cooling fluid path when the stopcock opens.
Casing 106 and fitting 108 may comprise a variety of polymer and/or metallic materials. In the exemplary embodiment, casing 106 and at least a portion of fitting 108 are off the-shelf items sized and adapted to receive and open a standard, commercially available pressurized fluid cartridge. The casing and seal opening components of the fitting may be fabricated by assembling and/or modifying components sold commercially by iSi Gmbh located in Vienna, Austria.
Cartridge 102 may be transported, stored, and optionally, used at room temperature. The cryogenic cooling fluid sealed within cartridge 102 may comprise COZ, N20, AZ-SOT"" fluorocarbon, andlor a variety of alternative cryogenic cooling fluids. As these fluids are at quite high pressures within cartridge 102, they may be in the form of a liquid or gas/liquid mixture, even at room temperature. The pressure of cooling fluid 104 within cartridge 102 will often be greater than 400 psi, preferably being about 500 psi or more at room temperature. It should be understood that the cartridge pressure will decreased during the treatment as cooling fluid is consumed. Advantageously, the quantity of cooling fluid 104 may be such that the cryosurgical system (including cryogenic fluid supply 14 and catheter 12) cool and maintain a target tissue within a predetermined temperature range for a time within a predetermined time range by the time the cooling fluid is consumed from the canister. In other words, by selecting the proper fluid supply cartridge and catheter structures, the cryogenic therapy may be self terminating without active intervention by an electronic control system, the operator, or the like. Cooling flow may cease when the fluid pressure within cartridge 102 is equal to ambient pressure, or may optionally be interrupted when the pressure drops below some threshold value.
Canister 102 will typically comprise a metallic structure. Suitable cartridges will hold quantities of cryogenic cooling fluid that are sufficient to cool the target tissue to the treatment temperature range for a time in the predetermined time range. Cartridges might have volumes between 2 cc and 100 cc (depending in part on the flash expansion temperatures of the cryogenic fluid), and may contain between about Sg and 30g of cooling fluid. A typical cartridge might contain a quantity of NZO
in a range from about 5 ml to about 20 ml, ideally having about a 10 ml or 8 grams of N20 liquid at about 750 psi. Conveniently, such cartridges are commercially available for use in whipped cream dispensers. As explained below, canister 102 may be at room temperature or even chilled, but will preferably be warmed gently prior to use.
Although the above discussion occasionally refers to structures and techniques for enhancing the efficiency of cryogenic cooling, known cryogenic cooling techniques are capable of inducing temperatures well below the preferred treatment temperature ranges for use with the present invention. To moderate the cooling of the target tissue and provide antiproliferative benefits, the systems of the present invention may optionally rely on thermal insulation 72, as described above with reference to Fig. 1.
Alternatively, a motor 122 may drivingly engage stopcock 120 so as to intermittently interrupt the flow of cooling fluid to the balloon. By cycling of the cooling fluid flow on and off, the present invention takes advantage of the thermal transients of the cooling system to prevent the tissue from reaching the low temperatures associated with a steady state cooling flow.
A variety of structures might be used to intermittently interrupt the flow of cooling fluid to the cryosurgical probe. In the embodiment of Fig. 2, an output shaft of an electrical motor assembly might be attached to a modified commercially available medical stopcock valve. Suitable motors might be powered from a standard wall outlet or batteries, and a reduction drive unit might be used to reduce the speed of the stopcock valve rotation to about one cycle per second. The drive motor may have a fixed speed to provide a temperature within a single predetermined temperature range, or may have a variable speed to actively control the temperature by varying the cycle speed, to alter the predetermined treatment temperature range for a particular treatment, and/or to provide the predetermined temperature range given a particular ambient condition, cryosurgical probe configuration, and the like.
Refernng now to Figs. 3A through C, alternative cooling fluid interrupters 124 may comprise a solenoid valve 126 coupled to a timer 128.
Solenoid valve 126 will preferably have a relatively low (dead) space, and will generally have a non-metallic body. Timer 128 may comprise an electro-mechanical timer, a circuit (such as an R-C timing circuit), or the like. Fabricating the solenoid valve body of a non-metallic material can help avoid the conduction of energy out of the system.
Minimizing dead space in the flow path of the valve helps the valve from acting as an expansion chamber, which might otherwise rob energy from the system.
Referring now to Fig. 3B, a motor-driven rotating valve provides fluid communication from cartridge 102 to balloon 30 when a passage of the valve member 130 is aligned with a passage of the valve body 132, and blocks flow when the passage of the valve member is blocked by the valve body. This is the general case of the motor driven stopcock illustrated in Fig. 2. A variety of valve passage configurations might be used to provide multiple flow cycles per rotation of valve member 130. For example, the valve member may include a pair of orthogonal passages in an "X"
configuration, thereby providing four flow cycles per rotation of the valve member. Flow can further be modified by changing the diameter of the passage or passages within valve member 130, the configuration of passages in valve body 132, the speed of rotation of the valve, and the like. Advantageously, a variety of flow cycles can be achieved.
Refernng now to Fig. 3C, cooling fluid flow may alternatively be pulsed by intermittently impinging on a deformable cooling flow conduit 134. Suitable conduits might include a polyamide tube having an inner diameter in a range from about 0.012" to about 0.035" with a relatively thick tubal wall. An exemplary deformable conduit comprises a polyamide tube having an inner diameter of 0.016" and a relatively thick wall of about 0.0015", and also having a PTFE lining of about 0.0005".
Deformable conduit 134 may be pinched between a flat plate 136 and solenoid 138. Suitable small solenoids may be battery powered, and may optionally include a mechanical advantage mechanism to provide enough force to substantially or entirely occlude the cooling flow. Alternatively, a pressurized cylinder/piston arrangement might be used, thereby providing significantly higher forces for a given size.
Such a pneumatic cylinder may be powered by any source of pressurized fluid, including an external pressurized air source, cartridge 102, or the like. Regardless of the specific pinch actuator, cycling of the flow cycle may again be provided by a timer 128, which may comprise an electromechanical timer, an R-C circuit, a mechanical or pressure actuated timing mechanism, or the like. It should be understood that the timer may be incorporated into the pinch actuation mechanism.
The benefits from the use of a flow interrupter can be understood with reference to Figs. 4 and SA through C. If cartridge 102 contains NZO at 750 psi, and if the cartridge is placed in an ice bath (thereby providing a convenient and reproducible initial condition), flash expansion of the cooling fluid to a pressure between atmospheric (14.7 psi) and 100 psi will result in cryogenic fluid temperatures in a range from about -45° C to about -90° C. Such low temperatures are useful, for example, for therapies in which cryogenic ablation of tissues is desired. Surprisingly, it may be beneficial to gently warm the cartridge to enhance the fluid pressure and cooling system performance.
Hence, alternative predetermined initial conditions might be provided by warming canister 102, preferably to about body temperature (with a hot plate, water bath, or the like) or even by holding the canister in a person's pocket (which may warm the canister to about 33°C). Still further predetermined initial temperatures may simply comprise operating room temperature.
To provide apoptosis and/or programmed cell death so as to inhibit hyperplasia and/or neoplasia of a blood vessel related to angioplasty, stenting, rotational or directional artherectomy, or the like, it will often be desirable to provide more moderate cryogenic treatment temperatures. A wide variety of other therapies may also benefit from these treatment temperatures, including the formation of cryogenic lesions within the coronary atrium for treatment of atrial fibrillation, and the like.
As a particular example, the cardiac tissue ablation devices and methods described in PCT
Patent Application WO 98/49957, published on November 12, 1998 (the full disclosure of which is incorporated herein by reference) might benefit from treatment temperatures significantly higher than about -30° C, in other words, significantly warmer than cooled tissue temperatures provided by many cryosurgical methods.
Referring now to Fig. SA, manually opening stopcock 120 of cryogenic fluid supply system 14 illustrated in Fig. 2 will typically result in a steady state flow of cooling fluid to balloon 30, resulting in a tissue temperature profile which quickly (often in about 2 seconds or less) drops down to a temperature of about -30° C
or less. Engaged blood vessel region will remain at this low temperature until cooling fluid 104 is fully consumed. Such cold treatment temperatures may induce necrosis, or may possibly be moderated by providing an insulation material between the cooling fluid and the engaged tissue, by narrowing the exhaust gas port so as to raise the pressure within balloon 30, or the like. The limited quantity of cooling fluid in cartridge 102 limits the treatment time without requiring active intervention by the surgeon.
Refernng now to Fig. 5B, cryogenic treatment temperatures can be modulated by intermittently cycling fluid flow. Specifically, flow is reduced and/or stopped significantly before the tissue reaches the nadir temperature. At this point, the body will absorb energy out of the system, raising the temperature of the treatment tissue.
The interrupter may cycle the flow on and off to keep the system at a relatively stable temperature for the duration of treatment. Ideally, the on and off cycling can be controlled by a simple fixed timer so as to reach a temperature between about -5° C and about -25°C during each cycle. In the exemplary embodiment, the tissue is maintained within a temperature range from about -5° C to about -25° C
throughout at least some of, and often most of, the thermal cycles. In some embodiments, a temperature feedback mechanism may be employed to modify the cooling cycles by altering a drive signal provided from controller 18 to the interrupter.
Referring now to Fig. 5C, a cryogenic cooling balloon having a diameter of about 2.5 mm and a length of about 4 cm was cooled by a NZO cartridge having a volume of about 10 cc. The cartridge was at about body temperature when flow began, providing a pressure of about 750 psi. A stopcock disposed along the flow path between cartridge 102 and balloon 30 was rotated at a speed of about one rotation per second by an electric motor. Balloon 30 was placed in body temperature water in this benchtop experiment, and temperatures were measured at an outer surface of the balloon.
These experiments produced the treatment temperatures shown in these two different experimental cooling runs.
A method for using the modulated temperature cryogenic system 10 is illustrated in Figs. 6A through C. Typically, catheter 12 is introduced into the vasculature through an introducer sheath, most often using the widely known Seldinger technique. A
guidewire GW is maneuvered through the vessel, and catheter 12 is advanced over the guidewire and positioned adjacent diseased portion DP a vessel wall VW.

Once balloon 30 is in position, the balloon can be inflated in a conventional manner to dilate the vessel, as illustrated in Fig. 6B. As can be understood with reference to Fig. 10, dilation may occur using an outer angioplasty balloon using conventional contrast fluid 40 to facilitate fluoroscopically directing a dilation procedure.
Alternatively, the vessel may be dilated using a separate angioplasty catheter, an axially displaced angioplasty balloon, or using the cryogenic balloon itself. In still further alternatives, cryogenic cooling may be initiated prior to or during dilation.
Regardless, cooling will preferably be effected by coupling a disposable cartridge to balloon 30 so that a cryogenic cooling fluid contained within the cartridge is transmitted to the balloon.
Cooling flow between the cartridge and balloon 30 will be interrupted intermittently so as to modulate the treatment temperature, so that a surface layer 88 of vessel wall VW
thermally engaged by balloon 30 cycles within a treatment temperature range from about -5° C to about -25° C for a time in a range from about 10 to about 60 seconds. As a result, this treated tissue layer undergoes apoptosis, thereby avoiding and/or reducing the proliferative response of the luminal wall to dilation.
As can also be understood with reference to Figs. 6A and 6C, plaque P or other occlusive matter may coat a portion of the vessel's lumen L. To treat the vessel wall tissues lining lumen L at the desired treatment temperature, balloon 30 may be cooled so that an outer surface of the balloon has a temperature significantly below the desired tissue treatment temperature range. Specifically, balloon 30 may be cooled to have an outer surface temperature selected to compensate for a thickness of occlusive matter disposed between the balloon surface and the target vessel tissue, with the selected balloon temperature typically decreasing with increasing occlusive matter thickness. The thickness of the occlusive matter may be measured in a blood vessel using a variety of techniques, including intravascular ultrasound (IVLJS), fluoroscopy, and the like.
While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, a variety of modifications, changes, and adaptations will be obvious to those of skill in the art. For example, a variety of endovascular therapies may benefit from the antiproliferative effects of the present invention, including angioplasty, stenting, directional and rotational atherectomy, and the like. Alternative treatment probes may also benefit from the moderated cryogenic treatment temperatures provided by the interrupted cooling fluid flow described hereinabove, including open surgical procedures effected by manipulating a hand-held rigid cryosurgical probe shaft supplied from conveniently cryosurgical fluid supply systems. Where ablation of a tissue most easily accessed through the vasculature is desired, the use of a disposable cartridge in combination with a flexible endovascular catheter may allow lesions having a predetermined size to be formed, with the total amount of cooling limited by the amount of cryogenic cooling fluid available within the cartridge. Hence, the scope of the present invention is limited solely by the appended claims.

Claims (27)

1. A cryogenic fluid delivery system for use with a cryosurgical probe having a cryogenic fluid input and a cooling surface for engaging a target tissue, the cryogenic delivery system comprising:
a cooling fluid container having a cryogenic fluid output;
a cooling fluid path coupling the fluid output of the container to the fluid input of the probe; and a flow interrupter disposed along the cooling fluid path, the interrupter intermittently inhibiting cryogenic cooling fluid flow from the container to the probe so as to limit cooling by the cooling surface.
2. The cryogenic delivery system of claim 1, wherein the flow interrupter comprises a solenoid valve.
3. The cryogenic delivery system of claim 1, wherein the flow interrupter comprises a valve member rotatably engaging a valve body, so as to provide fluid communication when the valve member is in a first rotational position and inhibiting fluid communication when the valve member is in a second rotational position.
4. The cryogenic delivery system of claim 3, wherein the flow interrupter further comprises a motor drivingly coupled to the valve member.
5. The cryogenic delivery system of claim 3, wherein the valve body comprises a non-metallic housing.
6. The cryogenic delivery system of claim 1, wherein the fluid interrupter comprises a deformable cryogenic conduit and a solenoid having a driven member movable between a first position and a second position, the deformable conduit being open when the solenoid member is in the first position, the deformable conduit being occluded when the member is in the second position.
7 The cryogenic delivery system of claim 1, wherein the container comprises a single-use cartridge having a seal, and further comprising a cryogenic cooling fluid disposed within the cartridge and maintained under pressure by the seal when the cartridge is at room temperature.
8. The cryogenic delivery system of claim 7, wherein the cooling fluid has a quantity so as to maintain the tissue at a temperature in a predetermined range for a time in a predetermined range so as to effect a desired treatment of the target tissue.
9. A cryogenic fluid delivery system for use with a cryogenic probe having a cryogenic fluid input and a cooling surface, the delivery system comprising:
a cooling fluid container having a cryogenic fluid output;
cryogenic cooling fluid disposed in the fluid container;
a cooling fluid path coupling the fluid output of the container to the fluid input of the probe;
means disposed along the cooling fluid path for limiting cooling of the cooled surface by intermittently inhibiting cooling fluid flow from the container to the probe.
10. A single-use cryogenic fluid delivery system for use with a cryogenic endovascular catheter to inhibit hyperplasia of a diseased blood vessel region of a patient body, the cryogenic delivery system comprising:
a cooling fluid container;
a connector for coupling to the catheter;
a cooling fluid path providing fluid communication from the container to the connector, the path having a seal;
cryogenic cooling fluid disposed within the fluid container, the cooling fluid having a quantity and being at a pressure such that the catheter will cool the blood vessel to a temperature in a predetermined temperature range so as to inhibit hyperplasia when the connector is coupled to the catheter and the seal is opened.
11. The cryogenic delivery system of claim 10, wherein the cryogenic fluid is held at the pressure by the container when the container is at room temperature or warmer.
12. The cryogenic delivery system of claim 11, wherein the quantity of the cryogenic fluid is sufficient to maintain the blood vessel within the temperature range for a time in a predetermined time range.
13. The cryogenic delivery system of claim 12, the desired treatment comprising inhibition of hyperplasia or neoplasia, wherein the quantity and pressure of the cryogenic fluid are sufficient to cool a surface of the diseased blood vessel region to a temperature from about -5° C to about -25° C for a time from about 10 to about 60 seconds.
14. The cryogenic delivery system of claim 10, wherein the container comprises a disposable cartridge, and further comprising a casing receiving the container and threadably engaging a fitting so that rotation of the fitting breaches a seal of the casing.
15. The cryogenic delivery system of claim 10, wherein the pressure of the cryogenic fluid in the container is in a range from about 400 to about 1000 psi.
16. The cryogenic delivery system of claim 15 wherein the cryogenic fluid comprises N2O, the quantity of cryogenic fluid in the container in a range from about 5 to about 30 grams.
17. The cryogenic delivery system of claim 10, further comprising a fluid limiting device disposed between the container and the connector to limit cryogenic cooling of the diseased blood vessel region.
18. The cryogenic delivery system of claim 17, wherein the fluid limiting device intermittently interrupts transfer of the cryogenic cooling fluid from the canister to the catheter.
19. A method for treating a tissue of a patient body using a cooling surface of a cryosurgical probe, the method comprising:
coupling a cryogenic fluid canister to the probe, the canister containing a pressurized cryogenic cooling fluid; and flowing the cooling fluid from the canister toward the cooling surface of the probe; and intermittently interrupting the flow of cooling fluid to limit cooling of the tissue by the probe.
20. The method of claim 19, wherein the intermittently interrupting step comprises periodically inhibiting the flow of cooling fluid to inhibit cooling of the tissue below a predetermined temperature range.
21. The method of claim 20, wherein the intermittently interrupting step is performed so as to cycle a tissue temperature.
22. The method of claim 21, wherein the cycling tissue temperature reaches a temperature within a range from about -5° C to about -25° C for a time in a range from about 10 to about 60 seconds.
23. The method of claim 21, wherein the cycling tissue temperature has a frequency in a range from about 0.3 to about 3 hertz.
24. The method of claim 20, wherein the intermittently interrupting step inhibits cooling before the flow of the cooling fluid cools the tissue to a steady state temperature.
25. The method of claim 19, the probe comprising a balloon catheter having a balloon, wherein the flowing step inflates the balloon within a blood vessel.
26. The method of claim 19, further comprising warming the cooling fluid in the canister.
27. The method of claim 19, further comprising selecting a cooled balloon temperature based at least in part on a thickness of occlusive matter lining at a vessel, the tissue comprising a vessel wall of the vessel.
CA2367628A 1999-03-15 2000-03-14 Cryosurgical fluid supply Expired - Lifetime CA2367628C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/268,205 US6432102B2 (en) 1999-03-15 1999-03-15 Cryosurgical fluid supply
US09/268,205 1999-03-15
PCT/US2000/006744 WO2000054684A1 (en) 1999-03-15 2000-03-14 Cryosurgical fluid supply

Publications (2)

Publication Number Publication Date
CA2367628A1 true CA2367628A1 (en) 2000-09-21
CA2367628C CA2367628C (en) 2013-11-19

Family

ID=23021936

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2367628A Expired - Lifetime CA2367628C (en) 1999-03-15 2000-03-14 Cryosurgical fluid supply

Country Status (8)

Country Link
US (7) US6432102B2 (en)
EP (3) EP2292170B1 (en)
JP (1) JP4759144B2 (en)
AT (1) ATE449575T1 (en)
AU (1) AU765717B2 (en)
CA (1) CA2367628C (en)
DE (1) DE60043385D1 (en)
WO (1) WO2000054684A1 (en)

Families Citing this family (312)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220257B1 (en) * 2000-07-25 2007-05-22 Scimed Life Systems, Inc. Cryotreatment device and method
US5868735A (en) * 1997-03-06 1999-02-09 Scimed Life Systems, Inc. Cryoplasty device and method
US7027869B2 (en) * 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6306166B1 (en) * 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
US5971979A (en) * 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia
US6379378B1 (en) 2000-03-03 2002-04-30 Innercool Therapies, Inc. Lumen design for catheter
US6325818B1 (en) 1999-10-07 2001-12-04 Innercool Therapies, Inc. Inflatable cooling apparatus for selective organ hypothermia
US6464716B1 (en) 1998-01-23 2002-10-15 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6585752B2 (en) 1998-06-23 2003-07-01 Innercool Therapies, Inc. Fever regulation method and apparatus
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
US7371254B2 (en) 1998-01-23 2008-05-13 Innercool Therapies, Inc. Medical procedure
US6991645B2 (en) * 1998-01-23 2006-01-31 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6602276B2 (en) * 1998-03-31 2003-08-05 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US6685732B2 (en) 1998-03-31 2004-02-03 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US6575933B1 (en) 1998-11-30 2003-06-10 Cryocath Technologies Inc. Mechanical support for an expandable membrane
US20050228367A1 (en) * 1999-01-25 2005-10-13 Marwan Abboud Leak detection system for catheter based medical device
US6432102B2 (en) 1999-03-15 2002-08-13 Cryovascular Systems, Inc. Cryosurgical fluid supply
US7004936B2 (en) * 2000-08-09 2006-02-28 Cryocor, Inc. Refrigeration source for a cryoablation catheter
US6471694B1 (en) 2000-08-09 2002-10-29 Cryogen, Inc. Control system for cryosurgery
ATE308933T1 (en) 2000-06-23 2005-11-15 Cryocath Technologies Inc DEVICE FOR CRYOTREATMENT
US6955174B2 (en) * 2000-08-18 2005-10-18 Uryovascular Systems, Inc. Cryotherapy method for detecting and treating vulnerable plaque
US6450987B1 (en) 2001-02-01 2002-09-17 Innercool Therapies, Inc. Collapsible guidewire lumen
US7401049B2 (en) * 2001-05-29 2008-07-15 American Express Travel Related Services Company, Inc. System and method for a prepaid card issued by a foreign financial institution
US7094234B1 (en) * 2001-08-27 2006-08-22 Medcool, Inc. Interstitial brain cooling probe and sheath apparatus
JP2005503241A (en) * 2001-09-27 2005-02-03 ガリル メディカル リミテッド Cryoplasty apparatus and method
CA2461627A1 (en) * 2001-09-27 2003-04-03 Roni Zvuloni Apparatus and method for cryosurgical treatment of tumors of the breast
US7144418B1 (en) 2001-11-02 2006-12-05 Medcool, Inc. Method, and system for selective cerebral hypothermia
US6692487B2 (en) * 2002-01-23 2004-02-17 Endocare, Inc. Cryosurgical monitoring system
US7617005B2 (en) * 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US6860924B2 (en) 2002-06-07 2005-03-01 Nanoscale Materials, Inc. Air-stable metal oxide nanoparticles
IL151486A0 (en) * 2002-08-26 2003-04-10 Levin Alexander Cryosurgical instrument and its accessory system
US20040158237A1 (en) * 2003-02-11 2004-08-12 Marwan Abboud Multi-energy ablation station
US20040215177A1 (en) * 2003-04-24 2004-10-28 Scimed Life Systems, Inc. Therapeutic apparatus having insulated region at the insertion area
US7060062B2 (en) * 2003-06-04 2006-06-13 Cryo Vascular Systems, Inc. Controllable pressure cryogenic balloon treatment system and method
US7381207B2 (en) 2003-06-25 2008-06-03 Endocare, Inc. Quick disconnect assembly having a finger lock assembly
US7189228B2 (en) * 2003-06-25 2007-03-13 Endocare, Inc. Detachable cryosurgical probe with breakaway handle
US20040267338A1 (en) * 2003-06-25 2004-12-30 Kent Harrison Targeted tissue cooling within a body
JP2007504910A (en) 2003-09-12 2007-03-08 ミノウ・メディカル・エルエルシイ Selectable biased reshaping and / or excision of atherosclerotic material
NZ548680A (en) * 2003-12-22 2009-09-25 Ams Res Corp Cryosurgical devices for endometrial ablation
US7727228B2 (en) 2004-03-23 2010-06-01 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US8491636B2 (en) 2004-03-23 2013-07-23 Medtronic Cryopath LP Method and apparatus for inflating and deflating balloon catheters
US9555223B2 (en) 2004-03-23 2017-01-31 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US7534221B2 (en) * 2004-05-24 2009-05-19 The Trustees Of Columbia University In The City Of New York Devices and methods for protecting against distal embolisms
US8177779B2 (en) * 2004-06-02 2012-05-15 Boston Scientific Scimed, Inc. Controllable pressure cryogenic balloon treatment system and method
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US8876750B2 (en) * 2004-09-27 2014-11-04 Art, Limited Coaxial tubing system for phacoemulsification handpieces
US20060069385A1 (en) * 2004-09-28 2006-03-30 Scimed Life Systems, Inc. Methods and apparatus for tissue cryotherapy
US7604631B2 (en) * 2004-12-15 2009-10-20 Boston Scientific Scimed, Inc. Efficient controlled cryogenic fluid delivery into a balloon catheter and other treatment devices
US8206345B2 (en) * 2005-03-07 2012-06-26 Medtronic Cryocath Lp Fluid control system for a medical device
US7674256B2 (en) * 2005-03-17 2010-03-09 Boston Scientific Scimed, Inc. Treating internal body tissue
US7794455B2 (en) 2005-04-29 2010-09-14 Medtronic Cryocath Lp Wide area ablation of myocardial tissue
US7727191B2 (en) * 2005-05-13 2010-06-01 Medtronic Cryocath Lp Compliant balloon catheter
US7713266B2 (en) 2005-05-20 2010-05-11 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
US7850683B2 (en) * 2005-05-20 2010-12-14 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
WO2007005523A2 (en) * 2005-06-30 2007-01-11 Stc Consulting, Llc Method and apparatus for cryogenically treating lesions on biological tissue
US8221348B2 (en) * 2005-07-07 2012-07-17 St. Jude Medical, Cardiology Division, Inc. Embolic protection device and methods of use
US7963940B2 (en) * 2005-08-22 2011-06-21 Boston Scientific Scimed, Inc. Local perfusion device
IN206553B (en) * 2005-09-23 2008-07-25 Taraprakash Prabhakar Vartak
DE102005050344A1 (en) * 2005-10-20 2007-05-03 Siemens Ag Cryocatheter for medical investigation and treatment equipment for e.g. diagnosis and treatment of heart infarcts, has image capture device that maps region of vessel around balloon arranged near catheter tip
EP1968508B1 (en) 2005-12-22 2019-05-15 Hybernia Medical LLC Systems for intravascular cooling
US7662177B2 (en) 2006-04-12 2010-02-16 Bacoustics, Llc Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
US20080097251A1 (en) * 2006-06-15 2008-04-24 Eilaz Babaev Method and apparatus for treating vascular obstructions
US20070299433A1 (en) * 2006-06-27 2007-12-27 C2 Therapeutics Barrett's Esophagus Cryogenic Ablation System
US9814511B2 (en) * 2006-06-28 2017-11-14 Medtronic Cryocath Lp Variable geometry cooling chamber
US20100114269A1 (en) * 2006-06-28 2010-05-06 Medtronic Cryocath Lp Variable geometry balloon catheter and method
US20080027419A1 (en) * 2006-07-25 2008-01-31 Ams Research Corporation Cryoprobe with Integral Agent Delivery Device
JP2008023256A (en) * 2006-07-25 2008-02-07 Olympus Medical Systems Corp Endoscope system
ES2533580T3 (en) * 2006-08-28 2015-04-13 The Regents Of The University Of California Dynamic cooling of human skin using a non-toxic cryogenic agent without ozone depletion and minimal global warming potential
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
AU2007310991B2 (en) 2006-10-18 2013-06-20 Boston Scientific Scimed, Inc. System for inducing desirable temperature effects on body tissue
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
US9254162B2 (en) 2006-12-21 2016-02-09 Myoscience, Inc. Dermal and transdermal cryogenic microprobe systems
KR20120106880A (en) 2007-01-21 2012-09-26 헤모텍 아게 Medical product for treating stenosis of body passages and for preventing threatening restenosis
US8409185B2 (en) * 2007-02-16 2013-04-02 Myoscience, Inc. Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling
US8162929B2 (en) * 2007-06-01 2012-04-24 Boston Scientific Scimed, Inc. Cryoablation segment for creating linear lesions
US20080312644A1 (en) * 2007-06-14 2008-12-18 Boston Scientific Scimed, Inc. Cryogenic balloon ablation instruments and systems
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
WO2009065061A1 (en) 2007-11-14 2009-05-22 Myoscience, Inc. Pain management using cryogenic remodeling
EP3289992A1 (en) * 2007-11-21 2018-03-07 Adagio Medical, Inc. Flexible multi-tubular cryoprobe
EP2211743B1 (en) * 2007-11-21 2017-08-02 Adagio Medical, Inc. Flexible multi-tubular cryoprobe
US8579889B2 (en) * 2008-01-11 2013-11-12 Boston Scientific Scimed Inc. Linear ablation devices and methods of use
US8235977B2 (en) * 2008-01-11 2012-08-07 Boston Scientific Scimed, Inc. Ablation devices and methods of use
WO2009128014A1 (en) 2008-04-16 2009-10-22 Arbel Medical Ltd Cryosurgical instrument with enhanced heat exchange
US8814850B2 (en) * 2008-04-24 2014-08-26 Cryomedix, Llc Method and system for cryoablation treatment
JP2011519679A (en) 2008-05-06 2011-07-14 ウィルソン−クック・メディカル・インコーポレーテッド Devices and methods for delivering therapeutic agents
US20090299420A1 (en) * 2008-06-02 2009-12-03 Shuros Allan C Method and apparatus for cryotherapy and pacing preconditioning
JP5233031B2 (en) * 2008-07-15 2013-07-10 株式会社デージーエス・コンピュータ Cryotherapy planning device and cryotherapy device
US8845627B2 (en) * 2008-08-22 2014-09-30 Boston Scientific Scimed, Inc. Regulating pressure to lower temperature in a cryotherapy balloon catheter
US8672919B2 (en) 2008-09-18 2014-03-18 Cook Medical Technologies Llc Dual balloon catheter assembly
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US8465481B2 (en) * 2008-10-20 2013-06-18 Boston Scientific Scimed, Inc. Providing cryotherapy with a balloon catheter having a non-uniform thermal profile
US8529434B2 (en) * 2008-10-29 2013-09-10 Cook Medical Technologies Llc Endoscopic sheet delivery
CN102271603A (en) 2008-11-17 2011-12-07 明诺医学股份有限公司 Selective accumulation of energy with or without knowledge of tissue topography
US8382746B2 (en) 2008-11-21 2013-02-26 C2 Therapeutics, Inc. Cryogenic ablation system and method
JP5602757B2 (en) * 2008-12-11 2014-10-08 クック メディカル テクノロジーズ エルエルシー Endoscope sheet rolling device
EP2373239B1 (en) 2008-12-22 2013-08-14 Myoscience, Inc. Integrated cryosurgical system with refrigerant and electrical power source
US8361054B2 (en) 2008-12-23 2013-01-29 Cook Medical Technologies Llc Apparatus and methods for containing and delivering therapeutic agents
AU2009330149A1 (en) 2008-12-23 2011-06-23 Cryomedix Llc Isotherm-based tissue ablation control system and method
US8821485B2 (en) * 2009-01-29 2014-09-02 Boston Scientific Scimed, Inc. Employing a secondary sheath with an ablation catheter
US7967814B2 (en) 2009-02-05 2011-06-28 Icecure Medical Ltd. Cryoprobe with vibrating mechanism
US8945117B2 (en) 2009-02-11 2015-02-03 Boston Scientific Scimed, Inc. Insulated ablation catheter devices and methods of use
WO2010105158A1 (en) 2009-03-12 2010-09-16 Icecure Medical Ltd. Combined cryotherapy and brachytherapy device and method
US20100241113A1 (en) * 2009-03-20 2010-09-23 Boston Scientific Scimed, Inc. Protecting the phrenic nerve while ablating cardiac tissue
CA2756263A1 (en) * 2009-04-06 2010-10-14 Cryomedix Llc Single phase liquid refrigerant cryoablation system with multitubular distal section and related method
US8888768B2 (en) 2009-04-30 2014-11-18 Cryomedix, Llc Cryoablation system having docking station for charging cryogen containers and related method
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US8647337B2 (en) * 2009-06-23 2014-02-11 Stc Consulting, Llc Devices and methods for dispensing a cryogenic fluid
US20110152850A1 (en) * 2009-06-23 2011-06-23 Niedbala R Sam Devices and methods for dispensing a cryogenic fluid
EP3106116B1 (en) 2009-06-30 2018-08-01 Boston Scientific Scimed, Inc. Map and ablate open irrigated hybrid catheter
WO2011005421A2 (en) 2009-07-10 2011-01-13 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
EP2453938B1 (en) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US20110270238A1 (en) 2009-12-31 2011-11-03 Raed Rizq Compliant Cryoballoon Apparatus for Denervating Ostia of the Renal Arteries
US20110263921A1 (en) 2009-12-31 2011-10-27 Anthony Vrba Patterned Denervation Therapy for Innervated Renal Vasculature
US7967815B1 (en) 2010-03-25 2011-06-28 Icecure Medical Ltd. Cryosurgical instrument with enhanced heat transfer
EP2555699B1 (en) 2010-04-09 2019-04-03 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US7938822B1 (en) 2010-05-12 2011-05-10 Icecure Medical Ltd. Heating and cooling of cryosurgical instrument using a single cryogen
US8936592B2 (en) * 2010-06-03 2015-01-20 Ams Research Corporation Laser tissue ablation system
US8080005B1 (en) 2010-06-10 2011-12-20 Icecure Medical Ltd. Closed loop cryosurgical pressure and flow regulated system
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US20120029512A1 (en) 2010-07-30 2012-02-02 Willard Martin R Balloon with surface electrodes and integral cooling for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
CN103547229B (en) * 2010-08-05 2017-09-26 美敦力Af卢森堡有限责任公司 Cryogenic ablation device, the system and method modulated for renal nerve
CA2806892A1 (en) * 2010-08-26 2012-03-01 Cryomedix, Llc Cryoablation balloon catheter and related method
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US9084610B2 (en) 2010-10-21 2015-07-21 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US20120136344A1 (en) * 2010-10-26 2012-05-31 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
WO2012058430A2 (en) * 2010-10-27 2012-05-03 Cryomedix, Llc Cryoablation apparatus with enhanced heat exchange area and related method
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
EP4032486A1 (en) 2010-11-16 2022-07-27 TVA Medical, Inc. Devices for forming a fistula
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US11246653B2 (en) * 2010-12-07 2022-02-15 Boaz Avitall Catheter systems for cardiac arrhythmia ablation
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
CA2825033C (en) 2011-02-01 2018-08-28 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
WO2012161875A1 (en) 2011-04-08 2012-11-29 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
SG194150A1 (en) 2011-04-13 2013-11-29 Cryotherapeutics Gmbh Plaque stabilisation using cryoenergy
EP2701623B1 (en) 2011-04-25 2016-08-17 Medtronic Ardian Luxembourg S.à.r.l. Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
WO2012148966A2 (en) * 2011-04-25 2012-11-01 Brian Kelly Apparatus and methods related to selective thermal insulation of cryogenic balloons for limited cryogenic ablation of vessel walls
JP2014516723A (en) 2011-06-01 2014-07-17 ボストン サイエンティフィック サイムド,インコーポレイテッド Ablation probe with ultrasound imaging capability
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US8936594B2 (en) * 2011-06-14 2015-01-20 Aerin Medical Inc. Methods and devices to treat nasal airways
US9084592B2 (en) 2011-07-11 2015-07-21 C2 Therapeutics, Inc. Focal ablation assembly
AU2012283908B2 (en) 2011-07-20 2017-02-16 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
AU2012287189B2 (en) 2011-07-22 2016-10-06 Boston Scientific Scimed, Inc. Nerve modulation system with a nerve modulation element positionable in a helical guide
US9387031B2 (en) 2011-07-29 2016-07-12 Medtronic Ablation Frontiers Llc Mesh-overlayed ablation and mapping device
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
AU2012308464B2 (en) 2011-09-14 2016-10-20 Boston Scientific Scimed, Inc. Ablation device with ionically conductive balloon
WO2013040201A2 (en) 2011-09-14 2013-03-21 Boston Scientific Scimed, Inc. Ablation device with multiple ablation modes
WO2013052858A1 (en) * 2011-10-07 2013-04-11 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant cartridges for cryotherapeutic systems and associated methods of making and using
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
WO2013055815A1 (en) 2011-10-11 2013-04-18 Boston Scientific Scimed, Inc. Off -wall electrode device for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
US10058312B2 (en) 2011-10-26 2018-08-28 Medtronic Cryocath Lp Systems and methods for cryoadhesive transseptal punctures
WO2013067421A2 (en) * 2011-11-05 2013-05-10 Medtronic Ardian Luxembourg S.A.R.L. Systems, devices and methods for crynogenic renal neuromodulation
CN104023662B (en) 2011-11-08 2018-02-09 波士顿科学西美德公司 Hole portion renal nerve melts
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
KR102067583B1 (en) 2011-12-09 2020-01-17 메타벤션, 인크. Therapeutic neuromodulation of the hepatic system
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
EP3138521B1 (en) 2011-12-23 2019-05-29 Vessix Vascular, Inc. Apparatuses for remodeling tissue of or adjacent to a body passage
WO2013102072A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Ablation probe with ultrasonic imaging capability
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
CN104039257A (en) 2012-01-10 2014-09-10 波士顿科学医学有限公司 Electrophysiology system
CA2861116A1 (en) 2012-01-13 2013-07-18 Myoscience, Inc. Cryogenic probe filtration system
WO2013106859A1 (en) 2012-01-13 2013-07-18 Myoscience, Inc. Cryogenic needle with freeze zone regulation
CN104159534B (en) 2012-01-13 2017-02-22 肌肉科技股份有限公司 Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments
US9017318B2 (en) 2012-01-20 2015-04-28 Myoscience, Inc. Cryogenic probe system and method
EP2809253B8 (en) 2012-01-31 2016-09-21 Boston Scientific Scimed, Inc. Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
ES2741699T3 (en) 2012-04-27 2020-02-12 Medtronic Ardian Luxembourg Cryotherapeutic devices for renal neuromodulation
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US20140073907A1 (en) 2012-09-12 2014-03-13 Convergent Life Sciences, Inc. System and method for image guided medical procedures
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
US9113911B2 (en) 2012-09-06 2015-08-25 Medtronic Ablation Frontiers Llc Ablation device and method for electroporating tissue cells
CN104780859B (en) 2012-09-17 2017-07-25 波士顿科学西美德公司 Self-positioning electrode system and method for renal regulation
US9211156B2 (en) 2012-09-18 2015-12-15 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter with flat tip
CN104640513A (en) 2012-09-18 2015-05-20 波士顿科学医学有限公司 Map and ablate closed-loop cooled ablation catheter
WO2014047411A1 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10835305B2 (en) 2012-10-10 2020-11-17 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
WO2014059351A1 (en) 2012-10-11 2014-04-17 Tva Medical, Inc. Devices and methods for fistula formation
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
AU2014236149A1 (en) 2013-03-14 2015-09-17 Tva Medical, Inc. Fistula formation devices and methods therefor
US9241754B2 (en) 2013-03-15 2016-01-26 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
CN105208954B (en) 2013-03-15 2019-06-04 肌肉科技股份有限公司 Low temperature Blunt dissection method and apparatus
US9186197B2 (en) 2013-03-15 2015-11-17 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device for treating pain
US9131975B2 (en) 2013-03-15 2015-09-15 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US9610112B2 (en) 2013-03-15 2017-04-04 Myoscience, Inc. Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
US9023023B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
AU2014237950B2 (en) 2013-03-15 2017-04-13 Boston Scientific Scimed, Inc. Control unit for use with electrode pads and a method for estimating an electrical leakage
US9198707B2 (en) 2013-03-15 2015-12-01 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device and method
US11026737B2 (en) 2013-03-15 2021-06-08 Endocare, Inc. Cryogenic system and methods
US9668800B2 (en) 2013-03-15 2017-06-06 Myoscience, Inc. Methods and systems for treatment of spasticity
US9033966B2 (en) 2013-03-15 2015-05-19 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9023022B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device having release instrument
WO2014205399A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
WO2014205388A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
EP3016605B1 (en) 2013-07-01 2019-06-05 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
CN105377170A (en) 2013-07-11 2016-03-02 波士顿科学国际有限公司 Medical device with stretchable electrode assemblies
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
CN105682594B (en) 2013-07-19 2018-06-22 波士顿科学国际有限公司 Helical bipolar electrodes renal denervation dominates air bag
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
WO2015013301A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
CN105555218B (en) 2013-09-04 2019-01-15 波士顿科学国际有限公司 With radio frequency (RF) foley's tube rinsed with cooling capacity
CN105530885B (en) 2013-09-13 2020-09-22 波士顿科学国际有限公司 Ablation balloon with vapor deposited covering
US9468484B2 (en) * 2013-09-13 2016-10-18 Cryofocus Medtech (Shanghai) Co. Ltd. Automated balloon catheter fluid purging system
EP3049005B1 (en) 2013-09-24 2022-08-10 Adagio Medical, Inc. Endovascular near critical fluid based cryoablation catheter
US9687288B2 (en) 2013-09-30 2017-06-27 Arrinex, Inc. Apparatus and methods for treating rhinitis
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical instrument sacculus
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
US10271898B2 (en) 2013-10-25 2019-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
WO2015066521A1 (en) * 2013-11-01 2015-05-07 C2 Therapeutics, Inc. Cryogenic balloon ablation system
US10130409B2 (en) 2013-11-05 2018-11-20 Myoscience, Inc. Secure cryosurgical treatment system
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
CN106572881B (en) 2014-02-04 2019-07-26 波士顿科学国际有限公司 Substitution of the heat sensor on bipolar electrode is placed
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
US10646265B2 (en) 2014-02-24 2020-05-12 Cryotherapeutics Gmbh Heat exchanger unit for cryotherapy
US10492842B2 (en) 2014-03-07 2019-12-03 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
WO2015138998A1 (en) 2014-03-14 2015-09-17 Tva Medical, Inc. Fistula formation devices and methods therefor
US9855089B2 (en) 2014-03-21 2018-01-02 Medtronic Cryocath Lp Shape changing ablation balloon
US9925359B2 (en) * 2014-03-21 2018-03-27 Medtronic Cryocath Lp Balloon design to reduce distal length
US10610279B2 (en) * 2014-04-10 2020-04-07 Channel Medsystems, Inc. Apparatus and methods for regulating cryogenic treatment
WO2015160574A1 (en) 2014-04-17 2015-10-22 Adagio Medical, Inc. Endovascular near critical fluid based cryoablation catheter having plurality of preformed treatment shapes
US9895190B2 (en) 2014-04-28 2018-02-20 Warsaw Orthopedic, Inc. Devices and methods for radiofrequency ablation having at least two electrodes
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
US10646666B2 (en) 2014-08-27 2020-05-12 Tva Medical, Inc. Cryolipolysis devices and methods therefor
JP2017529169A (en) 2014-10-13 2017-10-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Tissue diagnosis and treatment using mini-electrodes
WO2016065337A1 (en) 2014-10-24 2016-04-28 Boston Scientific Scimed Inc. Medical devices with a flexible electrode assembly coupled to an ablation tip
JP6607938B2 (en) 2014-11-13 2019-11-20 アダージョ メディカル インコーポレイテッド Pressure-regulated refrigeration ablation system and related method
CN106999080B (en) 2014-12-18 2020-08-18 波士顿科学医学有限公司 Real-time morphological analysis for lesion assessment
US10603040B1 (en) 2015-02-09 2020-03-31 Tva Medical, Inc. Methods for treating hypertension and reducing blood pressure with formation of fistula
CA2980745C (en) * 2015-03-27 2023-10-24 Project Moray, Inc. Articulation systems, devices, and methods for catheters and other uses
US9414878B1 (en) 2015-05-15 2016-08-16 C2 Therapeutics, Inc. Cryogenic balloon ablation system
US10631893B2 (en) 2015-07-10 2020-04-28 Warsaw Orthopedic, Inc. Nerve and soft tissue removal device
EP3349676A4 (en) 2015-09-18 2019-05-15 Adagio Medical, Inc. Tissue contact verification system
US10864031B2 (en) 2015-11-30 2020-12-15 Adagio Medical, Inc. Ablation method for creating elongate continuous lesions enclosing multiple vessel entries
US10500373B2 (en) 2015-12-04 2019-12-10 Project Moray, Inc. Lateral articulation anchors for catheters and other uses
US10525233B2 (en) 2015-12-04 2020-01-07 Project Moray, Inc. Input and articulation system for catheters and other uses
CN105581838B (en) * 2015-12-31 2017-11-21 宁波胜杰康生物科技有限公司 A kind of novel tumor cryoablation conduit
US10874422B2 (en) 2016-01-15 2020-12-29 Tva Medical, Inc. Systems and methods for increasing blood flow
JP6979021B2 (en) 2016-01-15 2021-12-08 ティーブイエー メディカル, インコーポレイテッド Devices and methods for advancing wires
MX2018008565A (en) 2016-01-15 2018-08-23 Tva Medical Inc Devices and methods for forming a fistula.
JP7125349B2 (en) 2016-02-11 2022-08-24 アリネックス, インコーポレイテッド Method and device for image-guided posterior nasal nerve ablation
US10806899B2 (en) 2016-02-17 2020-10-20 Project Moray, Inc. Local contraction of flexible bodies using balloon expansion for extension-contraction catheter articulation and other uses
US11420021B2 (en) 2016-03-25 2022-08-23 Project Moray, Inc. Fluid-actuated displacement for catheters, continuum manipulators, and other uses
EP3432834B1 (en) 2016-03-25 2021-01-13 Project Moray, Inc. Fluid-actuated sheath displacement and articulation behavior improving systems for catheters
WO2017197323A1 (en) 2016-05-13 2017-11-16 Lee Ann S Methods and systems for locating and treating with cold therapy
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
WO2017200877A1 (en) 2016-05-20 2017-11-23 C2 Therapeutics, Inc. Cryogenic ablation system with rotatable and translatable catheter
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
CN109600988B (en) 2016-06-15 2021-08-31 阿里内克斯股份有限公司 Device and method for treating the outer surface of the nasal cavity
US10939965B1 (en) 2016-07-20 2021-03-09 Arrinex, Inc. Devices and methods for treating a nerve of the nasal cavity using image guidance
US11071566B2 (en) * 2016-08-24 2021-07-27 Covidien Lp Introducing trocar with cryo-fixation of access cannula
AU2017331090C1 (en) 2016-09-25 2023-08-03 Tva Medical, Inc. Vascular stent devices and methods
CN109996490B (en) 2016-09-28 2023-01-10 项目莫里股份有限公司 Base station, charging station and/or server for robotic catheter systems and other uses, and improved articulation apparatus and systems
EP3518806A4 (en) 2016-09-28 2020-06-17 Project Moray, Inc. Arrhythmia diagnostic and/or therapy delivery methods and devices, and robotic systems for other uses
US11253312B2 (en) 2016-10-17 2022-02-22 Arrinex, Inc. Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use
EP3551107B1 (en) * 2016-12-09 2023-01-18 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
WO2018191013A1 (en) * 2017-04-11 2018-10-18 Cryterion Medical, Inc. Pressure control assembly for cryogenic balloon catheter system
US10905861B2 (en) 2017-04-25 2021-02-02 Project Moray, Inc. Matrix supported balloon articulation systems, devices, and methods for catheters and other uses
JP7300999B2 (en) 2017-04-28 2023-06-30 アリネックス, インコーポレイテッド Systems and methods for locating blood vessels in the treatment of rhinitis
US11564725B2 (en) 2017-09-05 2023-01-31 Adagio Medical, Inc. Ablation catheter having a shape memory stylet
JP2021502196A (en) * 2017-11-13 2021-01-28 バイオコンパティブルズ ユーケー リミテッド Cryoablation system with magnetic resonance imaging detection
WO2019099677A1 (en) 2017-11-15 2019-05-23 Myoscience, Inc. Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods
WO2019099878A1 (en) * 2017-11-17 2019-05-23 Cryoconcepts Lp Portable electro-mechanical cryosurgical device
TWI781968B (en) * 2017-11-27 2022-11-01 香港商麗年控股有限公司 Apparatus that vaporizes substance, vaporizer system, method excuted by vaporizer system, and vapor-theraphy device
CN116869642A (en) * 2017-11-30 2023-10-13 波士顿科学医学有限公司 Compensation assembly for fluid injection line of intravascular catheter system
CA3087772A1 (en) 2018-01-10 2019-07-18 Adagio Medical, Inc. Cryoablation element with conductive liner
US11478298B2 (en) 2018-01-24 2022-10-25 Medtronic Ardian Luxembourg S.A.R.L. Controlled irrigation for neuromodulation systems and associated methods
US11065150B2 (en) * 2018-03-19 2021-07-20 Gyrus Acmi, Inc. Dual balloon fluid endometrial treatment of uterine tissue
US11633224B2 (en) 2020-02-10 2023-04-25 Icecure Medical Ltd. Cryogen pump
JP7282251B2 (en) * 2020-06-09 2023-05-26 上海導向医療系統有限公司 double layer cryoexpansion balloon
WO2022251813A1 (en) * 2021-05-24 2022-12-01 B2M Medical, Inc. Method and system of removing visceral fat

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125096A (en) * 1964-03-17 Compressor
US436691A (en) * 1890-09-16 Half to horace n
NL291694A (en) * 1962-04-30 1900-01-01
US3630203A (en) * 1969-12-11 1971-12-28 Air Prod & Chem Cryogenic biological apparatus
US3901241A (en) 1973-05-31 1975-08-26 Al Corp Du Disposable cryosurgical instrument
US3993075A (en) * 1975-12-24 1976-11-23 Dynatech Corporation Disposable, defrostable cryosurgical probe
US4275734A (en) * 1977-08-12 1981-06-30 Valleylab, Inc. Cryosurgical apparatus and method
US4336691A (en) 1979-12-13 1982-06-29 The Board Of Trustees Of The Leland Stanford Junior University Cryojet rapid freezing apparatus
US5019075A (en) 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US4754752A (en) 1986-07-28 1988-07-05 Robert Ginsburg Vascular catheter
JPS6446056U (en) 1987-09-17 1989-03-22
US5041089A (en) 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
US4911170A (en) * 1988-08-22 1990-03-27 General Electric Company High frequency focused ultrasonic transducer for invasive tissue characterization
US5147355A (en) * 1988-09-23 1992-09-15 Brigham And Womens Hospital Cryoablation catheter and method of performing cryoablation
US5191883A (en) 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US5151100A (en) 1988-10-28 1992-09-29 Boston Scientific Corporation Heating catheters
GB2226497B (en) 1988-12-01 1992-07-01 Spembly Medical Ltd Cryosurgical probe
US4946460A (en) * 1989-04-26 1990-08-07 Cryo Instruments, Inc. Apparatus for cryosurgery
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
WO1991005528A1 (en) 1989-10-19 1991-05-02 Granulab B.V. Device for cooling or heating a person
US5101636A (en) * 1990-03-20 1992-04-07 The Boc Group, Inc. Cryogen delivery apparatus and method for regulating the cooling potential of a flowing cryogen
US5342301A (en) 1992-08-13 1994-08-30 Advanced Polymers Incorporated Multi-lumen balloons and catheters made therewith
US5092841A (en) 1990-05-17 1992-03-03 Wayne State University Method for treating an arterial wall injured during angioplasty
US5196024A (en) 1990-07-03 1993-03-23 Cedars-Sinai Medical Center Balloon catheter with cutting edge
US5190539A (en) 1990-07-10 1993-03-02 Texas A & M University System Micro-heat-pipe catheter
ZA917281B (en) 1990-09-26 1992-08-26 Cryomedical Sciences Inc Cryosurgical instrument and system and method of cryosurgery
US5117870A (en) * 1991-04-01 1992-06-02 Beckman Instruments, Inc. Pinch valve
US5275595A (en) 1992-07-06 1994-01-04 Dobak Iii John D Cryosurgical instrument
US6623516B2 (en) * 1992-08-13 2003-09-23 Mark A. Saab Method for changing the temperature of a selected body region
US5383855A (en) 1992-08-20 1995-01-24 Medex, Inc. Electronically monitored angioplasty system
US5383853A (en) 1992-11-12 1995-01-24 Medtronic, Inc. Rapid exchange catheter
US5417653A (en) 1993-01-21 1995-05-23 Sahota; Harvinder Method for minimizing restenosis
US5486208A (en) 1993-02-10 1996-01-23 Ginsburg; Robert Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US6620188B1 (en) * 1998-08-24 2003-09-16 Radiant Medical, Inc. Methods and apparatus for regional and whole body temperature modification
US5501681A (en) 1993-11-12 1996-03-26 Neuwirth; Robert S. Intrauterine cryoablation cauterizing apparatus and method
US5458612A (en) 1994-01-06 1995-10-17 Origin Medsystems, Inc. Prostatic ablation method and apparatus for perineal approach
US5417689A (en) * 1994-01-18 1995-05-23 Cordis Corporation Thermal balloon catheter and method
JP3263275B2 (en) * 1994-04-05 2002-03-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus
GB2289510A (en) * 1994-05-10 1995-11-22 Spembly Medical Ltd Connector
US5545195A (en) 1994-08-01 1996-08-13 Boston Scientific Corporation Interstitial heating of tissue
US5617739A (en) 1995-03-29 1997-04-08 Mmr Technologies, Inc. Self-cleaning low-temperature refrigeration system
US5644502A (en) 1995-05-04 1997-07-01 Mmr Technologies, Inc. Method for efficient counter-current heat exchange using optimized mixtures
US5733280A (en) 1995-11-15 1998-03-31 Avitall; Boaz Cryogenic epicardial mapping and ablation
US5771895A (en) * 1996-02-12 1998-06-30 Slager; Cornelis J. Catheter for obtaining three-dimensional reconstruction of a vascular lumen and wall
JP3745461B2 (en) 1996-07-29 2006-02-15 フジテクノ株式会社 Pressurizing means fixing method and pressurizing means fixing tool
US5820626A (en) * 1996-07-30 1998-10-13 Laser Aesthetics, Inc. Cooling laser handpiece with refillable coolant reservoir
US5899898A (en) 1997-02-27 1999-05-04 Cryocath Technologies Inc. Cryosurgical linear ablation
WO1998037822A1 (en) 1997-02-27 1998-09-03 Cryocath Technologies Inc. Method and apparatus for linear ablation
US6235019B1 (en) * 1997-02-27 2001-05-22 Cryocath Technologies, Inc. Cryosurgical catheter
US7220257B1 (en) 2000-07-25 2007-05-22 Scimed Life Systems, Inc. Cryotreatment device and method
US5868735A (en) * 1997-03-06 1999-02-09 Scimed Life Systems, Inc. Cryoplasty device and method
US5846235A (en) * 1997-04-14 1998-12-08 Johns Hopkins University Endoscopic cryospray device
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6027499A (en) * 1997-05-23 2000-02-22 Fiber-Tech Medical, Inc. (Assignee Of Jennifer B. Cartledge) Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa
US5902299A (en) 1997-07-29 1999-05-11 Jayaraman; Swaminathan Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
US5971979A (en) 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia
CA2318315A1 (en) 1998-01-14 1999-07-22 Conway-Stuart Medical, Inc. Electrosurgical apparatus for treating gastroesophageal reflux disease (gerd) and method
US6379378B1 (en) 2000-03-03 2002-04-30 Innercool Therapies, Inc. Lumen design for catheter
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
WO2001064145A1 (en) 2000-03-01 2001-09-07 Innercool Therapies, Inc. Cooling therapies/device for angioplasty with restenosis
US6905494B2 (en) * 1998-03-31 2005-06-14 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US6368304B1 (en) * 1999-02-19 2002-04-09 Alsius Corporation Central venous catheter with heat exchange membrane
US6419643B1 (en) 1998-04-21 2002-07-16 Alsius Corporation Central venous catheter with heat exchange properties
US6066132A (en) * 1998-06-30 2000-05-23 Ethicon, Inc. Articulating endometrial ablation device
US6241718B1 (en) 1998-11-30 2001-06-05 Cryocath Technologies, Inc. Method for inhibiting restenosis
US6575933B1 (en) * 1998-11-30 2003-06-10 Cryocath Technologies Inc. Mechanical support for an expandable membrane
US6468268B1 (en) 1999-01-25 2002-10-22 Cryocath Technologies Inc. Cryogenic catheter system
US6830581B2 (en) * 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
US6428534B1 (en) 1999-02-24 2002-08-06 Cryovascular Systems, Inc. Cryogenic angioplasty catheter
US6432102B2 (en) 1999-03-15 2002-08-13 Cryovascular Systems, Inc. Cryosurgical fluid supply
US6514245B1 (en) 1999-03-15 2003-02-04 Cryovascular Systems, Inc. Safety cryotherapy catheter
US6468297B1 (en) 1999-02-24 2002-10-22 Cryovascular Systems, Inc. Cryogenically enhanced intravascular interventions
US6648879B2 (en) 1999-02-24 2003-11-18 Cryovascular Systems, Inc. Safety cryotherapy catheter
US6537271B1 (en) 2000-07-06 2003-03-25 Cryogen, Inc. Balloon cryogenic catheter
US6989009B2 (en) * 2002-04-19 2006-01-24 Scimed Life Systems, Inc. Cryo balloon

Also Published As

Publication number Publication date
US8333758B2 (en) 2012-12-18
JP2002538882A (en) 2002-11-19
DE60043385D1 (en) 2010-01-07
US20040167505A1 (en) 2004-08-26
AU3884200A (en) 2000-10-04
US6972015B2 (en) 2005-12-06
US20020099365A1 (en) 2002-07-25
US9050074B2 (en) 2015-06-09
ATE449575T1 (en) 2009-12-15
US20060212028A1 (en) 2006-09-21
JP4759144B2 (en) 2011-08-31
US7641679B2 (en) 2010-01-05
US20020183731A1 (en) 2002-12-05
US6432102B2 (en) 2002-08-13
CA2367628C (en) 2013-11-19
EP2147648B1 (en) 2016-07-20
EP2292170A3 (en) 2012-07-04
EP2147648A1 (en) 2010-01-27
WO2000054684A1 (en) 2000-09-21
US20020010460A1 (en) 2002-01-24
EP1164963A4 (en) 2005-10-26
EP1164963B1 (en) 2009-11-25
EP1164963A1 (en) 2002-01-02
EP2292170A2 (en) 2011-03-09
EP2292170B1 (en) 2015-05-20
US6811550B2 (en) 2004-11-02
AU765717B2 (en) 2003-09-25
US6786901B2 (en) 2004-09-07
US20100106148A1 (en) 2010-04-29
US20130103019A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
CA2367628C (en) Cryosurgical fluid supply
CA2415051C (en) Improved safety cryotherapy catheter
US6428534B1 (en) Cryogenic angioplasty catheter
AU2001284647A1 (en) Improved safety cryotherapy catheter
JP4833494B2 (en) Cryotherapy apparatus and method
CA2666334C (en) Endovascular cryotreatment catheter
US6648879B2 (en) Safety cryotherapy catheter
US9555223B2 (en) Method and apparatus for inflating and deflating balloon catheters

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200314